Safety and efficacy of dual vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of randomized clinical trials
ConclusionCompared with TAT, DAT shows a reduction in TIMI major or minor bleeding by 47% with comparable outcomes of MACE. Our findings support the concept that DAT may be a better option than TAT in many patients with AF following PCI.
Source: European Heart Journal - Category: Cardiology Source Type: research
More News: Angioplasty | Atrial Fibrillation | Bleeding | Cardiology | Clinical Trials | Coronary Angioplasty | Databases & Libraries | Heart | Heart Attack | Percutaneous Coronary Intervention | Science | Stroke | Thrombosis